Cathie Wood acquired 6.7 Million Twist Bioscience shares worth $195 Million. That's 1.35% of their equity portfolio (23rd largest holding). The investor owns 12.33% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q4 2019. Since then Cathie Wood bought shares nine more times and sold shares on three occasions. The investor's estimated purchase price is $455 Million, resulting in a loss of 57%.